Purpose Health, a subsidiary of Healthcare Triangle, has secured multiple multi-year contracts including a Master Services Agreement for EHR optimization and cybersecurity with a university health system, advisory work for rural hospitals in Idaho, Vermont, and New York under a federal Rural Health Transformation program, and IT services for a healthcare business unit's Global Capability Center. The company is also advancing AI solutions that automate hospital tasks like Medicaid renewals and claim denials. These developments position Purpose Health as a growing player in healthcare IT, supported by its recent invitation to join the CHIME Foundation and its experience spanning over 15 years in healthcare technology services. The momentum is expected to continue into 2027 as the company deepens client engagements and expands its AI offerings.
Purpose Health's recent multi-year contract wins and AI advancements offer context for readers following healthcare innovation. For readers following the health sector, here is Pluang's market snapshot as of Oct 22, 2026 17:11 WIB: out of 150 priced US health stocks, 66 rose and 77 fell. Notable movers include Dyne Therapeutics Inc. (DYN) at USD 16.48 with a 1-day change of +2.55% and Pluang order activity of 60% Sell / 40% Buy, Ionis Pharmaceuticals Inc. (IONS) at USD 45.39 with a 1-day change of +2.53%, and Heron Therapeutics Inc. (HRTX) at USD 0.33 with a 1-day change of -2.48% and Pluang order activity of 20% Sell / 80% Buy.
Drofa Comms has released the Women Leading the Way Digital Magazine 2026, aiming to highlight women experts in finance on equal terms with men. The digital magazine features insights from 25 industry professionals and covers topics like AI in wealth ...
Fortuna Mining Corp. will announce its financial results for the third quarter of 2026 on November 4, after market close. A conference call to discuss the results will be held on November 5 at 12 p.m. Eastern time, featuring the CEO and key executive...
Gogoro Inc., a leader in battery swapping technology for electric mobility, will announce its financial results for the third quarter ending September 30, 2026, on November 11 before the market opens. The company will hold a webcast at 7 a.m. Eastern...
Aclarion's Nociscan, a noninvasive scan for diagnosing painful lumbar discs, was validated in a new study by the London Spine Clinic showing up to 87% agreement with the invasive discography procedure. Nociscan offers a safer, less painful, and more ...
The PIMCO 0-5 Year High Yield Corporate Bond Index ETF provides a relatively high 7.6% distribution yield with a portfolio focused on non-investment-grade bonds. Its shorter duration helps reduce losses amid rising interest rates, and it benefits fro...
